 Ilango Balakrishnan
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 6 | 2025 | 348 | 0.860 |
Why?
| | Medulloblastoma | 6 | 2022 | 192 | 0.700 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 46 | 0.690 |
Why?
| | Cerebellar Neoplasms | 5 | 2022 | 150 | 0.620 |
Why?
| | Bone Marrow Cells | 2 | 2014 | 291 | 0.490 |
Why?
| | MicroRNAs | 3 | 2014 | 671 | 0.400 |
Why?
| | Genome, Human | 2 | 2014 | 394 | 0.400 |
Why?
| | Cell Line, Tumor | 12 | 2025 | 3106 | 0.380 |
Why?
| | Cell Cycle Proteins | 5 | 2022 | 577 | 0.370 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2025 | 1315 | 0.350 |
Why?
| | Aging | 1 | 2020 | 1769 | 0.340 |
Why?
| | Cell Proliferation | 8 | 2025 | 2340 | 0.320 |
Why?
| | Nuclear Proteins | 3 | 2017 | 644 | 0.260 |
Why?
| | Neoplastic Stem Cells | 2 | 2025 | 376 | 0.260 |
Why?
| | Brain Neoplasms | 4 | 2025 | 1137 | 0.250 |
Why?
| | Histones | 2 | 2020 | 585 | 0.240 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2025 | 28 | 0.240 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2024 | 29 | 0.230 |
Why?
| | Proto-Oncogene Proteins | 3 | 2022 | 636 | 0.230 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2020 | 421 | 0.220 |
Why?
| | Pyrazoles | 4 | 2022 | 403 | 0.220 |
Why?
| | Epigenomics | 2 | 2020 | 111 | 0.210 |
Why?
| | Genes, myc | 2 | 2020 | 48 | 0.200 |
Why?
| | Stromal Cells | 2 | 2014 | 104 | 0.200 |
Why?
| | Antineoplastic Agents | 3 | 2022 | 2039 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 60 | 0.190 |
Why?
| | Pyrimidinones | 2 | 2020 | 102 | 0.190 |
Why?
| | Radiation Tolerance | 1 | 2022 | 97 | 0.180 |
Why?
| | Rhabdoid Tumor | 1 | 2022 | 85 | 0.180 |
Why?
| | Chromatin | 2 | 2020 | 470 | 0.170 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 36 | 0.170 |
Why?
| | Down-Regulation | 2 | 2014 | 637 | 0.170 |
Why?
| | Brain Stem Neoplasms | 1 | 2020 | 87 | 0.170 |
Why?
| | Astrocytoma | 1 | 2020 | 120 | 0.170 |
Why?
| | Deoxycytidine | 1 | 2020 | 164 | 0.160 |
Why?
| | Apoptosis | 7 | 2024 | 2485 | 0.160 |
Why?
| | Lysine | 1 | 2020 | 266 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 952 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 509 | 0.150 |
Why?
| | RNA, Messenger | 3 | 2014 | 2705 | 0.140 |
Why?
| | Argonaute Proteins | 2 | 2014 | 29 | 0.140 |
Why?
| | Checkpoint Kinase 1 | 1 | 2016 | 30 | 0.130 |
Why?
| | Pteridines | 1 | 2016 | 22 | 0.130 |
Why?
| | Radiation-Sensitizing Agents | 1 | 2016 | 40 | 0.130 |
Why?
| | Immunophenotyping | 1 | 2017 | 311 | 0.130 |
Why?
| | Ependymoma | 1 | 2017 | 175 | 0.120 |
Why?
| | Tumor Suppressor Proteins | 1 | 2017 | 314 | 0.120 |
Why?
| | Jagged-1 Protein | 1 | 2014 | 24 | 0.110 |
Why?
| | Serrate-Jagged Proteins | 1 | 2014 | 29 | 0.110 |
Why?
| | Wnt-5a Protein | 1 | 2014 | 20 | 0.110 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2014 | 55 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2014 | 159 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2014 | 484 | 0.110 |
Why?
| | NF-kappa B | 1 | 2017 | 687 | 0.110 |
Why?
| | Cellular Microenvironment | 1 | 2014 | 79 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 124 | 0.100 |
Why?
| | Wnt Proteins | 1 | 2014 | 127 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2020 | 1858 | 0.100 |
Why?
| | Calcium-Binding Proteins | 1 | 2014 | 213 | 0.100 |
Why?
| | Biomarkers, Tumor | 2 | 2016 | 1171 | 0.100 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 377 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 530 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 381 | 0.090 |
Why?
| | Cerebellum | 1 | 2012 | 216 | 0.090 |
Why?
| | Cell Line | 2 | 2014 | 2768 | 0.090 |
Why?
| | Chemokine CXCL12 | 1 | 2010 | 79 | 0.090 |
Why?
| | Humans | 16 | 2025 | 129705 | 0.090 |
Why?
| | Base Sequence | 1 | 2014 | 2161 | 0.080 |
Why?
| | Child, Preschool | 3 | 2020 | 10565 | 0.080 |
Why?
| | Mutation | 1 | 2020 | 3674 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2848 | 0.080 |
Why?
| | Child | 4 | 2025 | 20963 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2014 | 736 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2014 | 1108 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2024 | 797 | 0.070 |
Why?
| | Mice | 5 | 2025 | 16585 | 0.070 |
Why?
| | Transcription Factors | 1 | 2014 | 1636 | 0.060 |
Why?
| | Animals | 6 | 2025 | 34733 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 614 | 0.060 |
Why?
| | Carcinogenesis | 1 | 2025 | 200 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 773 | 0.050 |
Why?
| | Cell Survival | 2 | 2016 | 1083 | 0.050 |
Why?
| | DNA Repair | 1 | 2024 | 208 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 45 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 75 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2010 | 2522 | 0.050 |
Why?
| | Cell Cycle | 2 | 2014 | 581 | 0.050 |
Why?
| | 3' Untranslated Regions | 2 | 2012 | 137 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 229 | 0.050 |
Why?
| | RNA Polymerase II | 1 | 2024 | 315 | 0.050 |
Why?
| | Teratoma | 1 | 2022 | 102 | 0.050 |
Why?
| | Quinazolines | 1 | 2022 | 245 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 214 | 0.040 |
Why?
| | Female | 3 | 2025 | 68561 | 0.040 |
Why?
| | Piperazines | 1 | 2022 | 327 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 579 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 494 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2024 | 1409 | 0.040 |
Why?
| | Prognosis | 2 | 2016 | 3801 | 0.030 |
Why?
| | Benzodiazepinones | 1 | 2016 | 16 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 828 | 0.030 |
Why?
| | Urea | 1 | 2016 | 75 | 0.030 |
Why?
| | Thiophenes | 1 | 2016 | 118 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2017 | 360 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2016 | 658 | 0.030 |
Why?
| | Cisplatin | 1 | 2016 | 292 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2020 | 2075 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 863 | 0.030 |
Why?
| | DNA Damage | 1 | 2016 | 377 | 0.030 |
Why?
| | Male | 1 | 2020 | 63544 | 0.030 |
Why?
| | Azepines | 1 | 2014 | 87 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2016 | 784 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 850 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 328 | 0.030 |
Why?
| | Cathepsin B | 1 | 2012 | 14 | 0.030 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2012 | 28 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1195 | 0.030 |
Why?
| | Triazoles | 1 | 2014 | 153 | 0.030 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2012 | 39 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 680 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2014 | 929 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 962 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4471 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1189 | 0.020 |
Why?
| | Neural Stem Cells | 1 | 2012 | 132 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 479 | 0.020 |
Why?
| | CD146 Antigen | 1 | 2010 | 41 | 0.020 |
Why?
| | Pyrimidines | 1 | 2014 | 444 | 0.020 |
Why?
| | Chemotaxis | 1 | 2010 | 130 | 0.020 |
Why?
| | Hematopoiesis | 1 | 2010 | 184 | 0.020 |
Why?
| | Cell Separation | 1 | 2010 | 313 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 1894 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2012 | 400 | 0.020 |
Why?
| | Genomics | 1 | 2014 | 716 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 615 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 730 | 0.020 |
Why?
| | Cell Movement | 1 | 2012 | 934 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2596 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2014 | 870 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1570 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2014 | 1696 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 1151 | 0.020 |
Why?
| | Fibroblasts | 1 | 2010 | 946 | 0.020 |
Why?
| | Phenotype | 1 | 2012 | 3063 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 4863 | 0.010 |
Why?
|
|
Balakrishnan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|